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Correlation Between Fatty Liver and
Lipidemia in Taiwanese
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Background: Fatty liver is associated with overweight, hyperlipidemia,
hyperglycemia, hyperuricemia and alcoholism. The aim of this study was to determine
the relationship between the severity of fatty liver and the composition of lipidemia.
Materials and Methods: Subjects with normal liver sonogram (138), mild fatty
liver (75), moderate fatty liver (95), and severe fatty liver (29) were randomly
collected from patients who underwent complete tests in the Health Test Center.
Age, gender, body mass index (BMI), blood pressure, aspartate aminotransferase
(AST), alanine aminotransferase (ALT), cholesterol and triglyceride concentrations,
low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol
(HDL-C), very low-density lipoprotein cholesterol (VLDL-C) and blood sugar data
were collected.
Results: BMI, blood pressure, AST, ALT, cholesterol and triglyceride
concentrations, LDL-C, and blood sugar were significantly higher, and HDL-C was
significantly lower in patients with fatty liver. Increases in BMI, triglyceride
concentration, VLDL-C and blood sugar were positively related to the severity of
fatty liver, while HDL-C was negatively related. Cholesterol concentration and LDL-C
were no higher in moderate and severe than in mild fatty liver. HDL-C was
significantly lower in males than in females for both normal subjects (46.4 (
12.9 vs 53.4 ( 15.2 mg%, p = 0.004) and subjects with fatty liver (38.8 ( 11.4 vs
46.4 ( 13.1 mg%, p < 0.001). In both sexes with mild fatty liver, HDL-C was
no lower than in normal liver, but was significantly higher than in moderate fatty
liver (46.6 ( 14.3 vs 40.1 ( 11.5 mg%, p = 0.02). The mean HDL-C in severe
fatty liver in males was 35.6 ( 6.2 mg%.
Conclusion: Serum cholesterol and triglyceride concentrations, LDL-C and blood
sugar were significantly higher, and HDL-C was significantly lower in fatty liver
than in normal liver. Patients with moderate and severe fatty liver had significantly
lower HDL-C concentrations, especially males with severe fatty liver (35.6 (
6.2 mg%). Low HDL-C is a risk factor for coronary heart disease.
(J Med Ultrasound 2003;11:60–5)
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INTRODUCTION
Fatty liver is common, occurring in about 25% to
37% of asymptomatic healthy subjects who undergo
a health check-up in Taiwan [1, 2]. Many factors
are associated with fatty liver, such as overweight,
hyperlipidemia, hyperglycemia, hyperuricemia and
alcoholism [1, 3, 4]. The risk factors for coronary
heart disease in Taiwanese with coronary artery
disease are age, sex, hypertension, diabetes mellitus
(DM), smoking, family history of coronary artery
disease, and dyslipoproteinemia [5]. Among serum
lipids, high-density lipoprotein cholesterol (HDL-C)
and apolipoprotein B are significantly abnormal in
Taiwanese with coronary artery disease [5]. A serum
triglyceride concentration of more than 130 mg/dL
is a good predictor of fatty liver in Taiwanese [6].
Serum triglyceride concentration is positively related
to the degree of fatty liver [3]. In addition, fatty
liver is an independent correlate of coronary risk
factors in the elderly [7]. The aim of this study was
to determine the relationship between the severity
of fatty liver and the composition of lipidemia in
order to understand the risk factors for heart disease
in subjects with fatty liver.
PATIENTS AND METHODS
One hundred and thirty-eight subjects with normal
liver sonogram, and 75 subjects with mild fatty liver,
95 with moderate fatty liver, and 29 with severe
fatty liver on liver sonogram were randomly collected
from patients who underwent complete tests in the
Health Test Center at Kaohsiung Chang Gung
Memorial Hospital, Taiwan, from 1999 to 2002.
Subjects who had one of the following conditions
were excluded: a history of hypertension, coronary
artery disease, DM, alcoholism, chronic renal disease,
cerebrovascular accident (CVA), and overt disease
in other organs, including autoimmune hepatitis,
copper metabolism disorder, use of hepatoxic
medication, and high iron saturation and serum
ferritins; electrocardiogram (ECG) showing or
suggesting ischemic heart disease (IHD); or fasting
blood sugar over 140 mg/dL. Because obese persons
have a high blood sugar due to insulin resistance
[8], subjects were enrolled if their fasting blood
sugar was between 126 mg/dL and 140 mg/dL. In
total, only eight subjects with severe fatty liver had
blood sugar in this range.
Liver ultrasonography (US) was performed by
experienced specialists using abdominal US with a
high-resolution real-time machine (Aloka SSD-2000,
Tokyo, Japan) and a 3.5 MHz convex probe. On
sonography, fatty liver is shown by the presence of
enhanced bright liver echo, increased attenuation in
liver parenchyma, blurred vessels, increased liver–
kidney contrast, and poor visualization of the
gallbladder wall and diaphragm. Fatty liver was
graded as mild, moderate, or severe according to
published methods [9].
Body weight and height were measured for all
subjects, and personal and medical history was
recorded, including age, sex, blood pressure, IHD,
CVA, and DM. Biochemistry data included
cholesterol (normal, < 200 mg%), triglyceride
(normal, < 150 mg%), HDL-C (normal, > 40 mg%),
low-density lipoprotein cholesterol (LDL-C; normal,
< 130 mg%), very low-density lipoprotein cholesterol
(VLDL-C, mg%), blood sugar (normal, < 126 mg/dL
for fasting blood sugar; < 140 mg/dL post cibum),
aspartate aminotransferase (AST; normal, < 34 U/L)
and alanine aminotransferase (ALT; normal,
< 36 U/L). Venous blood was sampled after a 12-
hour overnight fast, and samples were analyzed
using the Wako automatic analyzer (Hitachi Ltd,
Tokyo, Japan) and an enzymatic method.
Each item was analyzed by severity of fatty liver.
Statistical analysis was carried out using the Chi-
squared test and Student’s t test. A p value of less
than 0.05 was considered significant.
RESULTS
In total, 337 subjects were enrolled, 185 males and
152 females, with a mean age of 50.5 years (range,
23–78 years). There were no differences in gender
(p > 0.3) or age (p = 0.175) between subjects with
normal liver and fatty liver (Table 1). BMI, blood
pressure, AST, ALT, cholesterol, triglyceride, LDL-
C, VLDL-C, and blood sugar were all significantly
higher, and HDL-C was significantly lower in patients
with fatty liver (Table 1). HDL-C was no lower in
patients with mild fatty liver than in those with
normal liver (46.6 ( 14.3 vs 49.6 ( 14.3 mg%,
p = 0.47) (Table 2). Increases in BMI, triglyceride,
VLDL-C and blood sugar were positively related to
the severity of fatty liver, while HDL-C was
negatively related to the severity of fatty liver (Table
2). Cholesterol concentration and LDL-C were no
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higher in patients with moderate and severe than
those with mild fatty liver. ALT was significantly
higher in patients with moderate and severe
fatty liver than in subjects with normal liver
(46.2 ( 41.9 and 50.3 ( 35.8 vs 21.4 ( 16.3 U/L,
p < 0.001).
Age, BMI, cholesterol, LDL-C, triglyceride,
VLDL-C and blood sugar were similar in male and
female subjects (Table 3). HDL-C in normal male
subjects was significantly lower than that in females
(p = 0.004). HDL-C was significantly lower in males
with fatty liver than in females with fatty liver (38.8 (
11.4 vs 46.4 ( 13.1 mg%, p < 0.001). In subjects with
mild fatty liver, HDL-C was no lower than that in
subjects with normal liver, but was significantly
higher than that in patients with moderate fatty liver
(46.6 ( 14.3 vs 40.1 ( 11.5 mg%, p = 0.02). In
subjects with moderate or severe fatty liver, HDL-
C was significantly lower than in normal subjects
(male, p < 0.02; female, p < 0.03). Mean HDL-C
in males and females with severe fatty liver was
35.6 mg% and 40.1 mg%, respectively (Table 3).
Table 1. Age, body mass index, blood pressure, and laboratory data in subjects with normal and fatty liver
Normal (n = 138) Fatty liver (n = 199) p
Sex (M/F) 76/62 109/90 > 0.3
Age (yr) 49.4 ( 14.2 51.3 ( 11.0 0.175
BMI (kg/m2) 22.3 ( 3.2 26.6 ( 3.1 < 0.001
Systolic BP (mmHg) 122.2 ( 15.7 128 ( 17.3 0.001
Diastolic BP (mmHg) 79.5 ( 10.8 82.9 ( 10.1 0.003
AST (U/L) 21.5 ( 10.3 32.6 ( 31.3 < 0.001
ALT (U/L) 21.4 ( 16.3 41.5 ( 40.17 < 0.001
Cholesterol (mg%) 188.7 ( 36.6 207.9 ( 46.3 < 0.001
Triglyceride (mg%) 106.4 ( 51.8 200.2 ( 193.9 < 0.001
HDL-C (mg%) 49.6 ( 14.4 42.2 ( 12.7 < 0.001
LDL-C (mg%) 114.4 ( 32.1 124.9 ( 41.0 0.013
VLDL-C (mg%) 22.3 ( 14.8 34.9 ( 25.8 < 0.001
Blood sugar (mg%) 96.9 ( 11.0 106.6 ( 21.6 0.01
Data shown as mean ( standard deviation. BMI = body mass index; BP = blood pressure; AST = aspartate aminotransferase;
ALT = alanine aminotransferase; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol;
VLDL-C = very low-density lipoprotein cholesterol.
Table 2. Comparison of data among patients with normal, mild, moderate, or severe fatty liver
Normal Mild Moderate Severe p
(n = 138) (n = 75) (n = 95) (n = 29)
Sex (M/F) 76/62 38/37 54/41 17/12
Age (yr) 49.4 ( 14.2 52.5 ( 9.8 51.8 ( 11.7 46.3 ( 10.9 0.18
BMI (kg/m2) 22.3 ( 3.1* 25.3 ( 2.9* 27.2 ( 2.7* 28.5 ( 2.9 < 0.001
Cholesterol (mg%) 188.7 ( 36.6* 216.1 ( 42.7* 203.7 ( 44.8 200.3 ( 57.3 < 0.001
Triglyceride (mg%) 106.4 ( 51.8 162.3 ( 42.7 202.8 ( 111.3 289.8 ( 444.1 < 0.001
HDL-C (mg%) 49.6 ( 14.3 46.6 ( 14.3† 40.1 ( 11.5† 37.5 ( 8.1 < 0.001
LDL-C (mg%) 114.4 ( 32.1‡ 135.2 ( 40.1‡ 120.5 ( 43.4 112.5 ( 28.3 0.013
VLDL-C (mg%) 22.3 ( 14.8§ 29.9 ( 15.7 35.4 ( 18.1§ 45.4 ( 52.2 < 0.001
Blood sugar (mg/dL) 96.9 ( 11.0 101.1 ( 12.8 106.7 ( 20.0|| 114.4 ( 24.2|| 0.01
*p ) 0.001, †p = 0.02, ‡p = 0.002, §p < 0.001, ||p = 0.04. Data shown as mean ( standard deviation. BMI = body mass index;
HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; VLDL-C = very low-density
lipoprotein cholesterol.
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DISCUSSION
It is commonly accepted that the risk factors for
atherosclerosis and coronary artery disease are male
gender, hyperlipidemia, smoking, hypertension, DM,
low HDL-C, severe obesity, family history of IHD
and personal history of cerebrovascular disease. Many
of these are totally or partially beyond our control,
such as sex, DM, hypertension and family history
of disease. Thus, the control of hyperlipidemia,
smoking, and obesity becomes more important in the
prevention of coronary artery disease. In this study,
BMI, blood pressure, AST, ALT, cholesterol,
triglyceride, LDL-C, VLDL-C and blood sugar were
all significantly higher in fatty liver, and HDL-C
was significantly lower in fatty liver (Table 1). The
severity of fatty liver was positively related to
increases in BMI, hyperlipidemia and blood sugar.
In fatty liver, although cholesterol, LDL-C and blood
sugar were higher than in normal subjects, mean
Table 3. Differences between male and female patients
Male (n = 185) Female (n = 152) p
Age (yr)
Normal 50.2 ( 14.0 48.4 ( 14.7* NP
Mild 50.2 ( 10.8 54.8 ( 8.2
Moderate 47.4 ( 11.1 58.1 ( 9.5*
Severe 44.5 ( 10.2 48.9 ( 11.7
BMI (kg/m2)
Normal 22.7 ( 3.2† 21.9 ( 3.0* NP
Mild 25.2 ( 2.8† 25.3 ( 3.0*
Moderate 27.4 ( 2.5† 25.9 ( 3.0*
Severe 28.5 ( 2.9† 28.5 ( 3.2*
Cholesterol (mg%)
Normal 184.1 ( 37.0† 194.4 ( 35.7 NP
Mild 212.1 ( 37.2† 220.1 ( 47.9
Moderate 197.2 ( 36.5 212.9 ( 53.7
Severe 190.9 ( 29.5 213.7 ( 82.1
Triglyceride (mg%)
Normal 110.2 ( 56.4† 101.7 ( 45.5* NP
Mild 186.4 ( 83.4† 137.5 ( 57.0
Moderate 219.2 ( 123.5 179.4 ( 87.2
Severe 197.9 ( 104.4 419.9 ( 674.2*
HDL-C (mg%)
Normal 46.4 ( 12.9† 53.4 ( 15.2‡ 0.004
Mild 41.9 ( 12.0 51.3 ( 15.0 < 0.001
Moderate 37.7 ( 11.8† 43.7 ( 10.3‡
Severe 35.6 ( 6.2† 40.1 ( 9.9‡
LDL-C (mg%)
Normal 112.7 ( 33.4§ 116.5 ( 30.6 NP
Mild 132.2 ( 38.7§ 138.2 ( 41.8
Moderate 113.7 ( 34.0 130.3 ( 53.1
Severe 116.2 ( 29.1 107.3 ( 27.6
Blood sugar (mg/dL)
Normal 98.0 ( 11.4† 95.6 ( 10.4* NP
Mild 100.3 ( 9.7 102.0 ( 15.5
Moderate 104.5 ( 11.3 109.9 ( 28.7*
Severe 127.5 ( 41.6† 110.3 ( 16.6
*p ) 0.003; †p < 0.012; ‡p ) 0.03; §p = 0.05, normal vs fatty liver in each group. Data shown as mean ( standard deviation.
NP = no significant difference; BMI = body mass index; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density
lipoprotein cholesterol.
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values were near to or lower than normal limits
(207.9 vs 200 mg%, 124.9 vs 130 mg%, and 106.6
vs 126 mg/dL). Triglyceride and VLDL-C were
higher than normal limits (200.2 vs 150 mg% and
34.9 ( 25.8 vs 22.3 ( 14.8 mg%, p < 0.001) and
their concentrations increased with the severity of
fatty liver (Tables 1 and 2). The relationship of
triglyceride or VLDL-C to IHD is confounded by
a rise in cholesterol as VLDL-C increases, and
several population studies have shown that increased
triglyceride or VLDL-C is independently correlated
with premature IHD [8]. This study showed that
subjects with fatty liver had significantly abnormal
lipoprotein, higher blood sugar, and higher BMI.
Obesity is associated with insulin resistance in
peripheral tissues and with compensatory hyper-
insulinemia, and promotes enhanced production of
triglyceride- and cholesterol-rich lipoproteins by the
liver [8]. Therefore, fatty liver may result from
obesity and lead to dyslipoproteinemia. In this study,
the severity of fatty liver was positively related to
the increase in BMI, hyperlipidemia and blood sugar.
Therefore, it is important to control body weight to
reduce blood sugar, triglyceride, and VLDL-C to
avoid IHD.
Consistent with differences in the IHD risk
between males and females, mean HDL-C is about
25% higher in women than in men. This phenomenon
occurs because estrogen tends to increase and
androgen tends to lower HDL-C [8]. In this study,
HDL-C in normal females was higher than that
in males (53.4 ( 15.2 vs 46.4 ( 12.9 mg%, p =
0.004). This phenomenon was also found in subjects
with fatty liver (Table 3). In addition, HDL-C
decreased parallel to the severity of fatty liver in
both sexes, and HDL-C in males with severe fatty
liver was 35.6 ( 6.2 mg% (the lower limit of HDL-
C, 35 mg%).
A study of coronary artery disease in Taiwanese
concluded that lipoprotein concentrations, especially
those of HDL-C and apolipoprotein B, are signi-
ficantly abnormal in patients with coronary artery
disease [5]. In this study, HDL-C was significantly
lower in subjects with fatty liver than in normal
subjects (42.2 ( 12.7 vs 49.6 ( 14.4 mg%, p <
0.001). However, in patients with mild fatty liver,
HDL-C concentration was no lower than in normal
subjects (p = 0.47). HDL-C in patients with moderate
and severe fatty liver was significantly lower than
that in normal subjects, and that in patients with
severe fatty liver was as low as 37.5 ( 8.1 mg%
(Table 2). Our results are consistent with previous
reports [4, 7, 10]. The lowest HDL-C was found
in males with severe fatty liver.
Low HDL-C (< 35 mg/dL) is generally considered
to be a risk factor for atherosclerosis and is
statistically associated with an increased risk of
myocardial infarction [11]. In the Framingham study,
low HDL-C is a more potent lipid risk factor than
high cholesterol or LDL-C. Thus, low HDL-C is an
independent factor that is closely correlated to IHD
[8, 12]. In this study, although cholesterol and LDL-
C were not highest in patients with severe fatty liver,
HDL-C was significantly lower in patients with moder-
ate and severe fatty liver (lowest, 37.5 ( 8.1 mg%
in severe fatty liver. Therefore, a subject with moderate
or severe fatty liver is not a healthy person. A person,
especially a male, with moderate or severe fatty liver
is at high risk for coronary artery disease.
ALT was significantly higher in patients with
moderate and severe fatty liver (46.2 ( 41.9 and
50.3 ( 35.8 U/L, respectively), but AST was not
positively related to fatty liver. These results are
consistent with previous reports in Taiwanese [1–3].
Hence, fatty liver may cause ALT abnormality.
In this study, all subjects were selected from
those attending the Health Test Center without a
history of hypertension, coronary artery disease, DM,
alcoholism, chronic renal disease, CVA or overt
disease in other organs. Serum cholesterol,
triglyceride, LDL-C and blood sugar were all
significantly higher, and HDL-C was significantly
lower in patients with fatty liver. Among subjects
with fatty liver, increases in triglyceride, VLDL-C
and blood sugar were positively related to, and
HDL-C was negatively related to, the severity of
fatty liver (Table 2). Furthermore, patients with
moderate or severe fatty liver had significantly lower
HDL-C, especially males with severe fatty liver (as
low as 35.6 ( 6.2 mg%). Because low HDL-C is
a risk factor for coronary heart disease, we need to
pay more attention to subjects with moderate or
severe fatty liver.
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